Palantir closed at $198.84 on Oct. 26, up 1.06% from $196.75, and the session was constructive in a way the prior two were not: it opened at $198.10, dipped only to $192.91 and closed at 83% of the day's $7.14 range, outperforming the S&P 500's +0.70% and the Nasdaq's +0.82%. The move lifted price back to 1.41% above the rising ($196.08), 8.20% above the ($183.78) and 19.91% above the ($165.83), with the golden-cross spread widening to $17.95, so the primary uptrend is intact and the Oct. 16 breakdown to $184.45 remains fully repaired. Momentum improved at the margin for the first time in a week: the histogram narrowed to -1.050 from -1.187 with the line at 4.102 still below its 5.152 signal, (14) rose to 56.09 from 54.42, and added 16.33 million shares. But the quality of the advance remains questionable: Oct. 26 volume of 16.33 million was 0.74x the 20-day average of 22.08 million and 0.70x the 60-day average of 23.17 million, the second consecutive sub-average session, and at 359.57 million sits 18.9% below its Oct. 9 peak of 443.57 million. The macro backdrop improved — the fell 5.45% to 18.39, the 10-year Treasury held at 4.986% and the S&P 500 gained 0.70% — which removes some of the rate-driven multiple pressure that dominated the prior run. Fundamentals remain elite: 92.8% revenue growth, 84.80% gross margin, 47.12% operating margin, 49.01% net margin, 38.1% , $3.40 billion of operating cash flow and $9.198 billion of net cash against $211.4 million of debt. Six of six available quarters beat consensus by an average of 14.56%, and the fiscal-year estimate series is still trending up — FY2026 of $1.61804 is +9.62% over 90 days and FY2027 of $2.35568 is +12.47%, with two upward revisions to FY2027 in the last 30 days and one in the last week. Yet the quarterly estimates keep leaking: the current-quarter figure is $0.41097 versus $0.41452 sixty days ago with two downward revisions in 30 days, and the 90-day roll-up still records zero upgrades, zero downgrades and zero initiations even as published targets rise (Piper Sandler $231, Citigroup $250, Mizuho $245, Barclays $265, Goldman Sachs $230). Valuation is the binding constraint and it got marginally worse with the price: 84.41x forward earnings, roughly 122.9x FY2026 , 77.62x trailing sales, 174.16x , 48.88x book and a 0.45% free-cash-flow yield, against a mean target of $207.62 that now implies only +4.41%. With the Nov. 2 report 6 calendar days away, an $8.06 and 43.93% 20-day realized volatility, any pre-print position is an event trade rather than an investment entry. The rating stays HOLD on every horizon: the franchise, the trend and the improving macro deserve respect, but 84.41x forward earnings, a $202.55-$202.63 ceiling that has now rejected the stock twice, thin volume on the recovery and binary event risk do not compensate for the price of admission.
Decision
Live price
$199.42
Recommendation score
54%
54%
Confidence
64%
64%
Outlook by horizon
1M
HOLD
Near
6M
HOLD
Mid
1Y
HOLD
Long
Primary catalyst
The Nov. 2 earnings report, 6 calendar days away, is the single most market-moving item: consensus is near $0.41097 with revenue around $2.17 billion, and prior bundled coverage flagged a Q3 adjusted-expense step-up. With the stock at 84.41x forward earnings, an $8.06 and the mean target only 4.41% above spot, an in-line quarter may not be sufficient - the Oct. 21-22 rejection at $202.55-$202.63 left the stock under that ceiling, so a growth or margin shortfall could gap it far beyond $8.06, while a beat with sustained U.S. commercial momentum and rising guidance reopens the path to the $221.50 median and the $230-$250 target cluster.
The at 18.39 - down 5.45% and back inside the middle of the neutral band - permits standard sizing in principle, but 6 days to a binary print at 84.41x forward earnings and a 0.45% FCF yield argues for no more than half a normal single-name position, and preferably no new capital until after Nov. 2 settles. Existing holders should carry a satellite weight sized so that a 15-20% earnings gap is survivable and should not add into the $202.55-$202.63 failed-breakout band. If the clears 20 or the 10-year yield pushes back above 5.15%, cut sizing again regardless of the chart.
Thesis Snapshot
Why It Works
The strongest argument for owning PLTR here is that the primary uptrend was never broken, the Oct. 26 session repaired last week's damage, and the business is compounding faster than any large-cap software company in history. Price is 19.91% above a rising at $165.83, the golden cross has widened to $17.95, and the Oct. 16 -7.20% washout to $186.03 was fully retraced within three sessions. Oct. 26 was the best-looking bar of the sequence: open $198.10, low $192.91, high $200.05, close $198.84 - 83% of the range - a higher high, higher low and higher close that reclaimed the and outpaced the S&P 500's +0.70% and the Nasdaq's +0.82%. The fundamentals are genuinely elite rather than narrative-driven: 92.8% revenue growth to $1.94 billion, 149% U.S. commercial growth to $764 million, 157% net dollar retention, 84.80% gross margin, 47.12% operating margin, 49.01% net margin, 38.1% , $3.40 billion of operating cash flow, $9.198 billion of net cash against $211.4 million of debt and a 44.51x cash-to-debt ratio. Six of six available quarters beat by an average of 14.56%, fiscal-year estimates are up 9.62% (FY2026) and 12.47% (FY2027) over 90 days with FY2027 carrying two upward revisions in the last 30 days and one in the last week, and the sell side keeps adding: Piper Sandler to $231 on Oct. 23, Citigroup to $250 on Oct. 22, Mizuho to $245 on Oct. 15, Barclays initiating at Overweight with $265 on Oct. 9, Goldman Sachs upgrading to Buy with $230 on Oct. 8 - and the bundle's median target rose $4.00 to $221.50. Bundled Zacks coverage compounds the argument with a #1 (Strong Buy) rank and full-year consensus of +114.67% and +82.96% revenue growth. On tracking: the prior run's $182.00 stop was never approached (Oct. 26 low $192.91) and its $186-$196 entry zone remains unfilled at current prices, with the $210-$225 exit zone beginning 5.6% above spot.
What Breaks It
The strongest argument against owning PLTR is that every rally attempt keeps dying at the same ceiling, the recovery is happening on shrinking volume, and the analyst cushion is now thinner than a single day's range. Oct. 21 broke out to $202.55, Oct. 22 reversed to $196.19, Oct. 23 stalled at $197.49 and Oct. 26's $200.05 high still did not clear Oct. 15's $200.91 - the stock has now spent six sessions failing to reclaim ground it lost on Oct. 16. Worse, the Oct. 26 +1.06% came on only 16.33 million shares (0.74x the 20-day average, 0.70x the 60-day), the second consecutive sub-average session, and at 359.57 million remains 18.9% below its Oct. 9 peak of 443.57 million - the October rally into $212.94 was distributed into, not accumulated. At $198.84 the stock trades at 84.41x forward earnings, roughly 122.9x FY2026 , 77.62x trailing sales, 174.16x , 48.88x book and a 0.45% FCF yield, while the mean analyst target of $207.62 sits only +4.41% above spot - about half of one $8.06 . Momentum has not actually turned: the line at 4.102 is still below its 5.152 signal, at 56.09 is 20 points below its Oct. 9 peak of 76.29, and the histogram, while improving, has been negative since Oct. 16. The real short thesis is not a broken franchise but growth normalization meeting an unforgiving multiple, and the estimates already show the hairline crack: the current-quarter figure has been trimmed to $0.41097 from $0.41452 sixty days ago with two downward revisions in 30 days and one in the last week, the next-quarter number slipped to $0.46340 from $0.46450, FY2026 fell $0.00069 over seven days, and the 90-day roll-up records zero actual upgrades despite all the published target raises. Bundled coverage notes hedge-fund holders fell to 86 from 96 while Snowflake's rose to 103 from 80 and argues Snowflake at ~16x forward sales is the better risk-adjusted AI vehicle - a plausible source of relative underperformance independent of Palantir's own results. Add a at 18.39 that is only one headline from a Risk-Off regime and a print 6 days away with a flagged Q3 expense step-up, and the path from $198.84 is wider to the downside than +4.41% implies.
A daily close below the Oct. 26 low of $192.91, followed by a break of the Oct. 23 low of $190.57 and the Oct. 20-21 lows at $189.42-$189.88, and then of the at $183.78 and the Oct. 16 low of $184.45, would confirm that the Oct. 19-26 bounce was a reflex rally inside an unfinished distribution sequence and would invalidate the consolidation thesis outright. On the fundamental side, the longer-term case would need reassessment if FY2026 or FY2027 estimates roll over on a 30-day basis (FY2026 already slipped $0.00069 in a week) or if U.S. commercial growth decelerates sharply on Nov. 2.
Valuation and rate sensitivity: 84.41x forward , roughly 122.9x FY2026 , 77.62x trailing sales, 174.16x and a 0.45% FCF yield leave no cushion, and although the 10-year Treasury eased to 4.986% this session, a renewed move above 5.15% would compress this multiple independently of results.
Earnings gap risk: the Nov. 2 report is 6 days away with consensus near $0.41097 and roughly $2.17 billion of revenue, a previously flagged Q3 adjusted-expense step-up, and an $8.06 that will not contain an event-driven move - a 15-20% gap would exceed the entire $10.00 entry-to-stop distance.
Technical/distribution risk: the line (4.102) sits below its signal (5.152), price failed twice at $202.55-$202.63 and could not clear the Oct. 15 high of $200.91, is 18.9% below its Oct. 9 peak, and both of the last two up sessions traded at only 0.74x and 0.70x the 20- and 60-day volume averages.
Estimate revision risk: the current-quarter estimate has slipped to $0.41097 from $0.41452 sixty days ago with two downward revisions in 30 days and one in the last 7, the next-quarter estimate fell to $0.46340 from $0.46450, FY2026 is $0.00069 lower than a week ago, and the 90-day roll-up records zero actual upgrades - the pre-print bar is being lowered even as published price targets rise.
Positioning and rotation risk: reported hedge-fund holders fell from 96 to 86 quarter over quarter while Snowflake's rose from 80 to 103, and bundled coverage argues Snowflake is the better risk-adjusted AI vehicle at less than half the forward sales multiple (~16x versus ~45x) - a credible source of relative underperformance independent of Palantir's own results.
Macro/regime risk: the at 18.39 is inside the neutral band and fell 5.45% this session, but a push back through 20 would flip the regime to Risk-Off, where a 1.602-beta, 43.93% realized-volatility name historically absorbs an outsized share of the drawdown.
Data-quality risk: Bollinger Band fields are null, the number-of-analysts field is null, and insider records carry blank transaction types with implied prices 48-64% below spot, so several of the framework's standard inputs cannot be relied on in this run - conviction should be discounted accordingly.
Watch Next
Next earnings: Nov 2, 2026
The Nov. 2 earnings report, 6 calendar days away, is the single most market-moving item: consensus is near $0.41097 with revenue around $2.17 billion, and prior bundled coverage flagged a Q3 adjusted-expense step-up. With the stock at 84.41x forward earnings, an $8.06 and the mean target only 4.41% above spot, an in-line quarter may not be sufficient - the Oct. 21-22 rejection at $202.55-$202.63 left the stock under that ceiling, so a growth or margin shortfall could gap it far beyond $8.06, while a beat with sustained U.S. commercial momentum and rising guidance reopens the path to the $221.50 median and the $230-$250 target cluster.
Signal Dashboard
Decision inputs
6 signals
Fundamental
4.4%
Upside to analyst mean target
At $198.84 the market capitalization is $477.82 billion against 84.41x forward earnings, which capitalizes FY2027 consensus of $2.35568; on the nearer FY2026 estimate of $1.61804 the multiple is roughly 122.9x. Trailing is 171.41x, price-to-sales 77.62x, price-to-book 48.88x and 174.16x on $463.71 billion of enterprise value, while the 0.45% free-cash-flow yield on $2.159 billion of FCF falls far short of the 3% level normally treated as attractive and implies about 221x free cash flow. is a methodological minefield here: the bundle's derived metric of 1.70 divides forward by an aggressive trailing growth rate, whereas the FY2026-to-FY2027 bridge ($1.61804 to $2.35568, +45.6%) yields a of about 1.85 and bundled Zacks coverage cites 2.16 versus a 1.18 industry average — the latter two are the more honest reads for a company whose growth is mathematically decelerating from a 215.4% trailing rate. Bundled coverage also frames PLTR near 45x forward sales versus roughly 16x for Snowflake and about 130x free cash flow versus Snowflake's 99x. The analyst math offers almost nothing: the mean target of $207.62 implies +4.41%, the median of $221.50 implies +11.40%, the $80 low implies -59.8% and the $265 high implies +33.3%. Relative to its growth Palantir is expensive; it is priced for flawless execution, not merely for excellence.
Technical
Neutral
Trend quality
At $198.84, price sits 1.41% above the ($196.08), 8.20% above the ($183.78) and 19.91% above the ($165.83). The has been above the since roughly early September and the spread has widened to $17.95, so this remains an established, strengthening golden-cross structure with the primary uptrend intact. The short-term structure is a wide, unresolved consolidation between roughly $184.45 and $212.94 inside that uptrend. Oct. 26 opened at $198.10, held $192.91 as the low, tagged $200.05 and closed at $198.84 — a higher high, higher low and higher close than Oct. 23, which reclaimed the decisively. It is still, however, below the Oct. 15 high of $200.91, the Oct. 21 high of $202.55 and the Oct. 22 high of $202.63, so the double rejection at that band has not yet been repaired; the bulls need a close above $202.63 to break the pattern.
Earnings
6d
Accelerating
Q2 FY2026 of $0.41 beat the $0.34596 estimate by 18.51% on revenue of $1.94 billion, up 92.8% year over year, with U.S. commercial revenue up 149% to $764 million, net dollar retention of 157% and FY2026 revenue guidance raised to $8.150-$8.158 billion; the bundle does not disclose the post-release share-price reaction. The next print is Nov. 2, only 6 calendar days away per the event calendar, with current-quarter consensus of $0.41097 and roughly $2.17 billion of revenue per bundled Zacks coverage, plus a previously flagged Q3 adjusted-expense step-up. Only six quarters are available, so the 100% beat rate rests on a short sample and should not be extrapolated as a high-confidence statistical edge — the least impressive beat in the series (a 1.11% surprise in the March 2025 quarter) shows the surprises are not uniformly large. The reported series (0.13, 0.16, 0.21, 0.25, 0.33, 0.41) is still stepping higher, but the current-quarter consensus has been trimmed from $0.41452 sixty days ago to $0.41097 today and the next-quarter figure from $0.46450 to $0.46340, a divergence that argues the bar is being lowered going into the print rather than raised.
News
Mixed-Bullish
Headline tone
The Nov. 2 earnings report, 6 calendar days away, is the single most market-moving item: consensus is near $0.41097 with revenue around $2.17 billion, and prior bundled coverage flagged a Q3 adjusted-expense step-up. With the stock at 84.41x forward earnings, an $8.06 and the mean target only 4.41% above spot, an in-line quarter may not be sufficient - the Oct. 21-22 rejection at $202.55-$202.63 left the stock under that ceiling, so a growth or margin shortfall could gap it far beyond $8.06, while a beat with sustained U.S. commercial momentum and rising guidance reopens the path to the $221.50 median and the $230-$250 target cluster.
Macro
Neutral
4.99% 10Y / 18.4 VIX
The fell 5.45% to 18.39 and the S&P 500 rose 0.70% while the 10-year Treasury yield held at 4.986%, so the volatility-and-rate pressure that squeezed this 1.602-beta, 84.41x-forward-earnings name in the prior session has eased — but 18.39 is still inside the 15-20 neutral band, one headline away from Risk-Off, and a push back through 20 would hit this long-duration multiple hardest.
Stability
High-Beta Growth
Satellite Upside
Palantir is a real franchise rather than a narrative: 92.8% trailing revenue growth, an 84.80% gross margin, a 47.12% operating margin, $3.40 billion of operating cash flow, $9.198 billion of net cash against $211.4 million of debt and a 38.1% . The equity is far more fragile than the business. A 1.602 beta, 43.93% 20-day realized volatility, an $8.06 (4.05% of price) and 84.41x forward earnings leave the stock exposed to 25-35% drawdowns driven purely by multiple compression, with no deterioration in reported results required. The last four sessions show the mechanism in miniature: +4.74% on Oct. 21, -2.74% on Oct. 22, +0.29% on Oct. 23 and +1.06% on Oct. 26, all inside a $189.42-$202.63 band. That combination makes this a satellite growth position, not a core anchor: operating quality is durable, but the equity return still depends on near-perfect multi-year execution at an unforgiving valuation.
Analyst Spread
Mean Target
$207.62
High / Low
$80 / $265
Median Target
$221.50
Consensus range
$80 - $265
— analysts
Mean
$80$208$265
Consensus
The mean target of $207.62 implies about +4.41% upside from $198.84 and the median of $221.50 implies +11.40%, while the $80 low target implies -59.8% and the $265 high implies +33.3% — a roughly $185 (93% of spot) spread that signals substantial disagreement about fair value. The number-of-analysts field is null, so coverage depth cannot be confirmed from that field, though the recommendation tally contains 30 ratings and the posture is Buy-heavy at 19 bullish versus 3 bearish. The direction of travel in targets remains up (mean $206.62 to $207.62, median $217.50 to $221.50 week over week, with Piper Sandler $231, Citigroup $250, Barclays $265, Mizuho $245 and Goldman Sachs $230), but the crucial point is that the Street's own fair-value view now sits just 4.41% above spot — only about half of the $8.06 — after an 86.93% rally off the $106.37 52-week low and a 6.62% pullback from the $212.94 high. That is not a margin of safety for an event-driven entry.
Positioning Pulse
Insider Signal
Neutral
Net Bias
No recent activity
Insider Own.
3.5%
Institutional Own.
64.6%
Interpretation
With transaction types blank, implied prices far below the current quote and no dated Form-4 activity, there is no verifiable evidence of either discretionary insider buying or selling — the data supports no directional signal and must not be used to justify a bullish or bearish conclusion in either direction.
Notable activity
This run again lists three directly and indirectly held records: director Alexander D. Moore at 20,000 shares ($1,629,103), director Lauren Elaina Friedman Stat at 11,794 shares ($1,212,423, indirect) and director Alexandra W. Schiff at 4,000 shares ($286,540). Every transaction_type field is blank, the date fields are meaningless sequence numbers ('147', '148', '149'), and the implied per-share values (~$81.46, ~$102.80 and ~$71.64) are 48-64% below the current $198.84 close, indicating stale or misdated records rather than trades executed near the present price. The record set is also unstable relative to prior runs, which listed two different names — a data-quality red flag.
Market Context
Industry
Software - Infrastructure
Mixed-Bullish
Sentiment
20
Tracked names
10
Grouping
industry
Software - Infrastructure industry is currently Mixed-Bullish with an average recommendation score near 54. capital and conviction are improving across the group, and leadership is concentrated in MSFT, ORCL, PANW.
Rotation Drivers
Average recommendation deltas are trending higher across Software - Infrastructure industry, which suggests improving risk appetite inside the group.
1 names are rated bullish versus 1 bearish names, keeping the group tone mixed-bullish.
Leadership is concentrated in MSFT, ORCL, PANW, so those names are the cleanest read on group-level capital rotation.
Palantir remains one of the few enterprise AI names converting the narrative into reported results: revenue grew 92.8%, U.S. commercial revenue grew 149% to $764 million, net dollar retention reached 157% and FY2026 revenue guidance was raised to $8.150-$8.158 billion. The theme is still strengthening at the fundamental level - FY2026 and FY2027 estimates are up 9.62% and 12.47% over 90 days and analysts have lifted or initiated targets five times in six weeks, with the bundle's median target rising $4.00 week over week. But positioning is now differentiating by valuation rather than by theme: bundled coverage notes hedge-fund holders fell to 86 from 96 while Snowflake's rose to 103 from 80, and explicitly frames Snowflake as the better risk-adjusted way to own the same theme at roughly 16x forward sales versus Palantir's ~45x. The Oct. 26 tape offered modest relief - the fell 5.45% to 18.39 and PLTR outperformed the S&P 500 and Nasdaq - but one improving session does not reverse the multiple-driven de-rating that began at the $212.94 high.
Six days before the Nov. 2 print, and with the stock still capped at $202.63, the market must re-underwrite a 77.62x trailing-sales multiple against consensus of roughly $0.41097 and $2.17 billion of revenue in real time rather than on paper.
Hedge-fund holder counts moved in opposite directions in Q2: Palantir fell to 86 from 96 while Snowflake rose to 103 from 80, evidence of valuation-aware rotation within enterprise AI rather than uniform buying.
Palantir trades near 45x forward sales versus roughly 16x for Snowflake and about 130x free cash flow versus Snowflake's 99x per bundled coverage - a gap that makes PLTR the funding source when the theme cools, even as its own 90-day revisions remain positive.
Defense AI / Sovereign AI
Score: 30
Mixed-Bullish
Defense and sovereignty demand is a real second leg of the story rather than a slogan: bundled coverage cites a Mercury Systems engagement applying Palantir software to material planning and factory workflows for large-scale military programs, a reported $127 million Army order, and D.A. Davidson's $250 target explicitly citing rising customer interest in 'AI sovereignty', with a supporting Nvidia partnership on enterprise AI deployment. Co-founder Joe Lonsdale's Reuters commentary on AI regulation, potential Ukrainian defense acquisitions and a possible Pentagon role keeps the company adjacent to policy headlines without producing a dated, quantified catalyst. There is no defense backlog, book-to-bill or government-segment fund-flow series in this bundle, so this remains demonstrated commercial interest rather than confirmed capital rotation. Momentum in the theme is stable-to-strengthening on narrative but unverified on hard data, which is why the sentiment score stays moderate - and the month-old news timestamps mean none of these threads has been refreshed in this run.
Every defense and sovereignty thread compounds into the Nov. 2 report, where government-segment demand and contract timing will be re-underwritten alongside the U.S. commercial number that carries the valuation.
The Mercury Systems defense-industrial-base engagement and the reported $127 million Army order broaden disclosed use cases beyond commercial AIP deployments.
Sell-side target inflation with an explicit sovereignty rationale - D.A. Davidson to $250 on AI sovereignty, Piper Sandler to $231, Citigroup to $250, Mizuho to $245, Barclays initiating at $265 - shows analysts are already capitalizing sovereignty demand even without disclosed backlog data.
Key Stats
23 metrics total
Market Cap
$477.82B
P/E (TTM)
171.4
Forward P/E
84.4
Revenue Growth
92.8%
ROE
38.1%
Beta
1.60
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
77.6
Price / Book
48.9
EV / EBITDA
174.2
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
84.8%
Operating Margin
47.1%
Debt / Equity
2.1
Current Ratio
7.23x
Quick Ratio
7.09x
Positioning & Range
Short interest and 52-week location.
Short % Float
2.6%
Short Ratio
2.21x
52W High
$212.94
52W Low
$106.37
From 52W High
-6.6%
From 52W Low
86.9%
Company Classification
Sector and industry context.
Sector
Technology
Industry
Software - Infrastructure
Additional Signals
Free Cash Flow
$2159104512.00
Detailed Analysis
Valuation
At $198.84 the market capitalization is $477.82 billion against 84.41x forward earnings, which capitalizes FY2027 consensus of $2.35568; on the nearer FY2026 estimate of $1.61804 the multiple is roughly 122.9x. Trailing is 171.41x, price-to-sales 77.62x, price-to-book 48.88x and 174.16x on $463.71 billion of enterprise value, while the 0.45% free-cash-flow yield on $2.159 billion of FCF falls far short of the 3% level normally treated as attractive and implies about 221x free cash flow. is a methodological minefield here: the bundle's derived metric of 1.70 divides forward by an aggressive trailing growth rate, whereas the FY2026-to-FY2027 bridge ($1.61804 to $2.35568, +45.6%) yields a of about 1.85 and bundled Zacks coverage cites 2.16 versus a 1.18 industry average — the latter two are the more honest reads for a company whose growth is mathematically decelerating from a 215.4% trailing rate. Bundled coverage also frames PLTR near 45x forward sales versus roughly 16x for Snowflake and about 130x free cash flow versus Snowflake's 99x. The analyst math offers almost nothing: the mean target of $207.62 implies +4.41%, the median of $221.50 implies +11.40%, the $80 low implies -59.8% and the $265 high implies +33.3%. Relative to its growth Palantir is expensive; it is priced for flawless execution, not merely for excellence.
Balance Sheet
The reported 2.139 debt-to-equity ratio screens as leveraged in isolation but reflects a tiny absolute debt load against a large equity base rather than financial stress: $211.4 million of total debt against $9.409 billion of cash, or $9.198 billion of net cash and a 44.51x cash-to-debt ratio. Operating cash flow of $3.40 billion covers reported debt 16.08x, and current and quick ratios of 7.23 and 7.09 indicate exceptional liquidity. Free cash flow of $2.159 billion equals only a 0.45% yield on the $477.82 billion market cap and net cash is just 1.92% of market cap, so the balance sheet is fortress-like even though cash generation is small relative to the price being paid. of 38.1% and of 17.29% show high returns achieved without leverage, and there is no refinancing, covenant or dilution-for-survival risk embedded in this capital structure — a genuine differentiator against most high-multiple software peers.
Growth
Growth remains exceptional and broad-based: Q2 FY2026 revenue rose 92.8% year over year to $1.94 billion, U.S. commercial revenue rose 149% to $764 million, net dollar retention reached 157%, and reported earnings growth was 215.4%. Management raised FY2026 revenue guidance to $8.150-$8.158 billion from a prior $7.65-$7.662 billion range and lifted the fiscal 2026 U.S. commercial projection to more than $3.42 billion, while bundled Zacks consensus models full-year of $1.61 (+114.67%) on $8.19 billion of revenue (+82.96%). Consensus now implies roughly 45.6% growth from FY2026 ($1.61804) to FY2027 ($2.35568), a deceleration from the 215.4% trailing rate that is arithmetically unavoidable as the base scales — and that deceleration is precisely what an 84.41x forward multiple cannot tolerate. Note that Q2 adjusted figures cited in bundled coverage (62% adjusted operating margin, $1.22 billion adjusted free cash flow equal to 63% of revenue) are not comparable with the feed's 47.12% reported operating margin and $3.40 billion operating cash flow, and prior bundled coverage flagged a Q3 adjusted-expense step-up that could pressure sequential margins.
Business Quality
Within Technology / Software - Infrastructure, Palantir combines an 84.80% gross margin, 47.12% reported operating margin, 43.25% margin and 49.01% net margin with of 38.1% and of 17.29%. Current and quick ratios of 7.23 and 7.09, $3.40 billion of operating cash flow and $9.198 billion of net cash support a premium franchise assessment. Institutional ownership is 64.63% and insider ownership 3.46%, with short interest at only 2.59% of float and a 2.21 short ratio — there is no crowded short base to squeeze, which cuts both ways because there is also no forced-buying catalyst from positioning. These are top-decile software economics that justify a quality premium, but they do not justify any multiple: 77.62x trailing sales prices in growth that has to persist for years without a stumble.
Capital Allocation
Palantir holds $9.198 billion of net cash against $477.82 billion of market capitalization, so net cash equals only 1.92% of market cap and enterprise value is 0.97x market cap; it pays no dividend (0% payout ratio, 0% yield), and this bundle identifies no active buyback. About 2.3007 billion shares are outstanding against a float of 2.1098 billion. The company funds product and go-to-market expansion internally without issuing debt, which removes financing risk from the thesis entirely. However, no share-count history or current stock-based-compensation figure is supplied in this run, so prior estimates of roughly 3% annual SBC-related dilution cannot be verified or refreshed here — that remains an open question at a valuation where every basis point of dilution is expensive.
Estimate Revisions
Revision direction is positive at the fiscal-year horizon and negative at the quarterly horizon, and the split persists this week. FY2026 of $1.61804 compares with $1.61873 seven days ago, $1.61155 thirty days ago, $1.60272 sixty days ago and $1.47608 ninety days ago (+9.62% over 90 days), but the 7-day delta is slightly negative and the revision count shows one upward versus two downward moves over 30 days and one downward move in the last 7 days. FY2027 of $2.35568 compares with $2.35050, $2.32666, $2.31424 and $2.09448 (+12.47% over 90 days) and carries two upward revisions in the last 30 days and one in the last 7 — the one genuinely constructive revision series in the bundle. Against that, the current-quarter estimate of $0.41097 is below $0.41222 seven days ago, $0.41367 thirty days ago and $0.41452 sixty days ago, with two downward revisions over 30 days and one in the last 7; next-quarter of $0.46340 shows the same two-down pattern. The recommendation tally is 1 Strong Buy / 18 Buy / 8 Hold / 1 Sell / 2 Strong Sell (30 ratings) versus 1/19/9/1/1 a month ago — the bullish count slipped from 20 to 19 while the bearish count rose from 2 to 3. The action list remains supportive: Piper Sandler raised its target to $231 from $230 on Oct. 23, Citigroup to $250 from $245 on Oct. 22, Mizuho to $245 from $215 on Oct. 15, Barclays initiated at Overweight with $265 on Oct. 9 and Goldman Sachs upgraded to Buy with $230 on Oct. 8. Caveat: the 90-day roll-up still reports zero upgrades, zero downgrades and zero initiations, so the roll-up lags the action list — target inflation should not be confused with fresh earnings-estimate increases, because the near-term numbers are being trimmed, not raised.